Nuveen Asset Management, LLC Abb Vie Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 8,886,629 shares of ABBV stock, worth $1.52 Billion. This represents 0.49% of its overall portfolio holdings.

Number of Shares

8,886,629

Previous 9,107,229 2.42%

Holding current value

$1.52 Billion

Previous $1.41 Billion 14.66%

% of portfolio

0.49%

Previous 0.46%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $35.3 Million - $40.2 Million	-220,600 Reduced 2.42%	8,886,629 $1.62 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $185 Million - $209 Million	-1,345,476 Reduced 12.87%	9,107,229 $1.41 Billion
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $66.1 Million - $76.6 Million	-495,010 Reduced 4.52%	10,452,705 $1.56 Billion
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $56.8 Million - $70.6 Million	-428,384 Reduced 3.77%	10,947,715 $1.47 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $141 Million - $163 Million	-977,479 Reduced 7.91%	11,376,099 $1.81 Billion

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $168 Million - $201 Million	-1,212,368 Reduced 8.94%	12,353,578 $2 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $151 Million - $173 Million	-1,124,828 Reduced 7.66%	13,565,946 $1.82 Billion
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $234 Million - $298 Million	-1,701,065 Reduced 10.38%	14,690,774 $2.25 Billion
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $7.93 Million - $9.84 Million	60,090 Added 0.37%	16,391,839 $2.62 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $186 Million - $235 Million	1,727,890 Added 11.83%	16,331,749 $2.21 Billion
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $74.9 Million - $85 Million	-704,102 Reduced 4.6%	14,603,859 $1.58 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $211 Million - $235 Million	-2,007,205 Reduced 11.59%	15,307,961 $1.72 Billion
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $2 Million - $2.2 Million	19,506 Added 0.11%	17,315,166 $1.87 Billion
Q4 2020 May 17, 2021	BUY	$80.49 - $108.67 $62.4 Million - $84.2 Million	775,186 Added 4.69%	17,295,660 $1.85 Billion
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $289 Million - $390 Million	-3,592,348 Reduced 17.86%	16,520,474 $1.77 Billion
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $173 Million - $203 Million	-2,011,667 Reduced 9.09%	20,112,822 $1.76 Billion
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $510 Million - $683 Million	6,956,787 Added 45.87%	22,124,489 $2.17 Billion
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $137 Million - $208 Million	2,126,043 Added 16.3%	15,167,702 $1.16 Billion
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $187 Million - $234 Million	2,592,492 Added 24.81%	13,041,659 $1.15 Billion
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $53.9 Million - $64.8 Million	855,322 Added 8.92%	10,449,167 $791 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $596 Million - $761 Million	9,065,487 Added 1715.78%	9,593,845 $698 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $2.41 Million - $2.84 Million	-31,240 Reduced 5.58%	528,358 $42.6 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $13.5 Million - $16.7 Million	173,898 Added 45.09%	559,598 $51.6 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $10.3 Million - $11.4 Million	115,585 Added 42.79%	385,700 $36.5 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $470,088 - $556,220	5,236 Added 1.98%	270,115 $25 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $28.9 Million - $38.7 Million	-314,312 Reduced 54.27%	264,879 $25.1 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $7.15 Million - $7.84 Million	-79,796 Reduced 12.11%	579,191 $0
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $46 Million - $58.8 Million	658,987	658,987 $58.6 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Abb Vie Inc. Transaction History